Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats

Neurons synthesize NO, which may act as a retrograde messenger, involved in either potentiating or depressing neuronal excitability. NO may also play a role in the cerebral vasodilatory response to increased neuronal activity (i.e., seizures). In this study, two questions were asked: (1) is NO an en...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research 1994-09, Vol.658 (1), p.192-198
Hauptverfasser: Wang, Qiong, Theard, Mary A., Pelligrino, Dale A., Baughman, Verna L., Hoffman, William E., Albrecht, Ronald F., Cwik, Michael, Paulson, Olaf B., Lassen, Niels A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 198
container_issue 1
container_start_page 192
container_title Brain research
container_volume 658
creator Wang, Qiong
Theard, Mary A.
Pelligrino, Dale A.
Baughman, Verna L.
Hoffman, William E.
Albrecht, Ronald F.
Cwik, Michael
Paulson, Olaf B.
Lassen, Niels A.
description Neurons synthesize NO, which may act as a retrograde messenger, involved in either potentiating or depressing neuronal excitability. NO may also play a role in the cerebral vasodilatory response to increased neuronal activity (i.e., seizures). In this study, two questions were asked: (1) is NO an endogenous anticonvulsant or proconvulsant substance? and (2) is the cerebral blood flow (CBF) increase accompanying bicuculline (BC)-induced seizures mediated by NO? The experiments were performed in 300–400-g Wistar rats anesthetized with 0.6% halothane and 70% N 2O/30% O 2. CBF was measured using the intracarotid 133Xe clearance method or laser-Doppler flowmetry. EEG activity was recorded. Chronic treatment (4 days) with nitro- L-arginine ( L-NA), a potent NO synthase (NOS) inhibitor (400 mg/kg total), suppressed brain NOS by > 97% and prolonged seizure duration from 6±1 (saline-treated controls) to 12 ± 2 min. In the L-NA-treated group, the CBF increase was sustained as long as seizure activity remained, indicating that CBF was still tightly coupled to seizure activity. Interestingly, the supposed inactive enantiomer of L-NA, D-NA, also showed an inhibition of brain NOS activity, ranging from 87 to 100%. The duration of seizures in this group (average 8 ± 2 min) corresponded directly to the magnitude of reduction in NOS activity ( r = 0.83, P < 0.05). Specifically, the D-NA results indicated that NOS inhibition had to exceed 95% before any effect on seizure duration could be seen. Additional results demonstrated that only a total dose of 400 mg/kg of L-NA, given chronically was capable of prolonging the BC-induced CBF increase. With acute doses of 5 and 30 mg/kg L-NA, the time course of CBF changes after BC administration was not different from the control. These findings suggest that endogenous NO acts as an anticonvulsant perhaps via a negative feedback mechanism at the NMDA receptor. NO, however, does not appear to couple neuronal activation to increased CBF in this model.
doi_str_mv 10.1016/S0006-8993(09)90026-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16572800</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006899309900269</els_id><sourcerecordid>16572800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-53d219660649bf194a8614d59a6973efd82316203ae7dfef55752ae1c55a2a6e3</originalsourceid><addsrcrecordid>eNqFkcFuFDEMhiMEKsvCI1TKAaH2MJBkJpnNCaEKaKWqPQDnyJN4SlA2WZKZQnkX3pVMd7VXTrHl33b8_YSccvaWM67efWGMqWajdXvG9LlmTKhGPyErvulFo0THnpLVUfKcvCjlR03bVrMTctLLlsler8jfGz9lb2n67R3Ss5vbc-oLhUgxunSHMc1LNnmb4v0cSg3pME80pokC3aLzMKVM00in70h9tBmhLAG1mHHIEOgQUnJ0DOkXBWvTdgfxwcc7Ong72zkEH7Hx0c0WHS3o_8wZyzIgw1RekmcjhIKvDu-afPv08evFZXN9-_nq4sN1YzvBpka2TnCtFFOdHkauO9go3jmpQem-xdFtRMuVYC1g70YcpeylAORWShCgsF2TN_u5u5x-zlgms_XFYggQsRIwXMlebCq9NZF7oc2plIyj2WW_hfxgODOLLebRFrMwN0ybR1uMrn2nhwXzUKkduw4-1PrrQx2KhTBmiNaXo6xeqesBVfZ-L8MK495jNsV6jBWdz2gn45L_z0f-AVirq54</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16572800</pqid></control><display><type>article</type><title>Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Wang, Qiong ; Theard, Mary A. ; Pelligrino, Dale A. ; Baughman, Verna L. ; Hoffman, William E. ; Albrecht, Ronald F. ; Cwik, Michael ; Paulson, Olaf B. ; Lassen, Niels A.</creator><creatorcontrib>Wang, Qiong ; Theard, Mary A. ; Pelligrino, Dale A. ; Baughman, Verna L. ; Hoffman, William E. ; Albrecht, Ronald F. ; Cwik, Michael ; Paulson, Olaf B. ; Lassen, Niels A.</creatorcontrib><description>Neurons synthesize NO, which may act as a retrograde messenger, involved in either potentiating or depressing neuronal excitability. NO may also play a role in the cerebral vasodilatory response to increased neuronal activity (i.e., seizures). In this study, two questions were asked: (1) is NO an endogenous anticonvulsant or proconvulsant substance? and (2) is the cerebral blood flow (CBF) increase accompanying bicuculline (BC)-induced seizures mediated by NO? The experiments were performed in 300–400-g Wistar rats anesthetized with 0.6% halothane and 70% N 2O/30% O 2. CBF was measured using the intracarotid 133Xe clearance method or laser-Doppler flowmetry. EEG activity was recorded. Chronic treatment (4 days) with nitro- L-arginine ( L-NA), a potent NO synthase (NOS) inhibitor (400 mg/kg total), suppressed brain NOS by &gt; 97% and prolonged seizure duration from 6±1 (saline-treated controls) to 12 ± 2 min. In the L-NA-treated group, the CBF increase was sustained as long as seizure activity remained, indicating that CBF was still tightly coupled to seizure activity. Interestingly, the supposed inactive enantiomer of L-NA, D-NA, also showed an inhibition of brain NOS activity, ranging from 87 to 100%. The duration of seizures in this group (average 8 ± 2 min) corresponded directly to the magnitude of reduction in NOS activity ( r = 0.83, P &lt; 0.05). Specifically, the D-NA results indicated that NOS inhibition had to exceed 95% before any effect on seizure duration could be seen. Additional results demonstrated that only a total dose of 400 mg/kg of L-NA, given chronically was capable of prolonging the BC-induced CBF increase. With acute doses of 5 and 30 mg/kg L-NA, the time course of CBF changes after BC administration was not different from the control. These findings suggest that endogenous NO acts as an anticonvulsant perhaps via a negative feedback mechanism at the NMDA receptor. NO, however, does not appear to couple neuronal activation to increased CBF in this model.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/S0006-8993(09)90026-9</identifier><identifier>PMID: 7530579</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>Amino Acid Oxidoreductases - antagonists &amp; inhibitors ; Animals ; Anticonvulsants - metabolism ; Arginine - analogs &amp; derivatives ; Arginine - pharmacology ; Bicuculline ; Biological and medical sciences ; Cerebral blood flow ; Cerebrovascular Circulation - drug effects ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Male ; Medical sciences ; Nervous system (semeiology, syndromes) ; Neurology ; Nitric oxide (NO) ; Nitric Oxide - physiology ; Nitric Oxide Synthase ; Nitroarginine ; NMDA receptor ; Rats ; Rats, Wistar ; Seizure ; Seizures - chemically induced ; Seizures - physiopathology ; Stereoisomerism</subject><ispartof>Brain research, 1994-09, Vol.658 (1), p.192-198</ispartof><rights>1994 Elsevier Science B.V. All rights reserved</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-53d219660649bf194a8614d59a6973efd82316203ae7dfef55752ae1c55a2a6e3</citedby><cites>FETCH-LOGICAL-c420t-53d219660649bf194a8614d59a6973efd82316203ae7dfef55752ae1c55a2a6e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006899309900269$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4209162$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7530579$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Qiong</creatorcontrib><creatorcontrib>Theard, Mary A.</creatorcontrib><creatorcontrib>Pelligrino, Dale A.</creatorcontrib><creatorcontrib>Baughman, Verna L.</creatorcontrib><creatorcontrib>Hoffman, William E.</creatorcontrib><creatorcontrib>Albrecht, Ronald F.</creatorcontrib><creatorcontrib>Cwik, Michael</creatorcontrib><creatorcontrib>Paulson, Olaf B.</creatorcontrib><creatorcontrib>Lassen, Niels A.</creatorcontrib><title>Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Neurons synthesize NO, which may act as a retrograde messenger, involved in either potentiating or depressing neuronal excitability. NO may also play a role in the cerebral vasodilatory response to increased neuronal activity (i.e., seizures). In this study, two questions were asked: (1) is NO an endogenous anticonvulsant or proconvulsant substance? and (2) is the cerebral blood flow (CBF) increase accompanying bicuculline (BC)-induced seizures mediated by NO? The experiments were performed in 300–400-g Wistar rats anesthetized with 0.6% halothane and 70% N 2O/30% O 2. CBF was measured using the intracarotid 133Xe clearance method or laser-Doppler flowmetry. EEG activity was recorded. Chronic treatment (4 days) with nitro- L-arginine ( L-NA), a potent NO synthase (NOS) inhibitor (400 mg/kg total), suppressed brain NOS by &gt; 97% and prolonged seizure duration from 6±1 (saline-treated controls) to 12 ± 2 min. In the L-NA-treated group, the CBF increase was sustained as long as seizure activity remained, indicating that CBF was still tightly coupled to seizure activity. Interestingly, the supposed inactive enantiomer of L-NA, D-NA, also showed an inhibition of brain NOS activity, ranging from 87 to 100%. The duration of seizures in this group (average 8 ± 2 min) corresponded directly to the magnitude of reduction in NOS activity ( r = 0.83, P &lt; 0.05). Specifically, the D-NA results indicated that NOS inhibition had to exceed 95% before any effect on seizure duration could be seen. Additional results demonstrated that only a total dose of 400 mg/kg of L-NA, given chronically was capable of prolonging the BC-induced CBF increase. With acute doses of 5 and 30 mg/kg L-NA, the time course of CBF changes after BC administration was not different from the control. These findings suggest that endogenous NO acts as an anticonvulsant perhaps via a negative feedback mechanism at the NMDA receptor. NO, however, does not appear to couple neuronal activation to increased CBF in this model.</description><subject>Amino Acid Oxidoreductases - antagonists &amp; inhibitors</subject><subject>Animals</subject><subject>Anticonvulsants - metabolism</subject><subject>Arginine - analogs &amp; derivatives</subject><subject>Arginine - pharmacology</subject><subject>Bicuculline</subject><subject>Biological and medical sciences</subject><subject>Cerebral blood flow</subject><subject>Cerebrovascular Circulation - drug effects</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Nitric oxide (NO)</subject><subject>Nitric Oxide - physiology</subject><subject>Nitric Oxide Synthase</subject><subject>Nitroarginine</subject><subject>NMDA receptor</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Seizure</subject><subject>Seizures - chemically induced</subject><subject>Seizures - physiopathology</subject><subject>Stereoisomerism</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFuFDEMhiMEKsvCI1TKAaH2MJBkJpnNCaEKaKWqPQDnyJN4SlA2WZKZQnkX3pVMd7VXTrHl33b8_YSccvaWM67efWGMqWajdXvG9LlmTKhGPyErvulFo0THnpLVUfKcvCjlR03bVrMTctLLlsler8jfGz9lb2n67R3Ss5vbc-oLhUgxunSHMc1LNnmb4v0cSg3pME80pokC3aLzMKVM00in70h9tBmhLAG1mHHIEOgQUnJ0DOkXBWvTdgfxwcc7Ong72zkEH7Hx0c0WHS3o_8wZyzIgw1RekmcjhIKvDu-afPv08evFZXN9-_nq4sN1YzvBpka2TnCtFFOdHkauO9go3jmpQem-xdFtRMuVYC1g70YcpeylAORWShCgsF2TN_u5u5x-zlgms_XFYggQsRIwXMlebCq9NZF7oc2plIyj2WW_hfxgODOLLebRFrMwN0ybR1uMrn2nhwXzUKkduw4-1PrrQx2KhTBmiNaXo6xeqesBVfZ-L8MK495jNsV6jBWdz2gn45L_z0f-AVirq54</recordid><startdate>19940926</startdate><enddate>19940926</enddate><creator>Wang, Qiong</creator><creator>Theard, Mary A.</creator><creator>Pelligrino, Dale A.</creator><creator>Baughman, Verna L.</creator><creator>Hoffman, William E.</creator><creator>Albrecht, Ronald F.</creator><creator>Cwik, Michael</creator><creator>Paulson, Olaf B.</creator><creator>Lassen, Niels A.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>19940926</creationdate><title>Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats</title><author>Wang, Qiong ; Theard, Mary A. ; Pelligrino, Dale A. ; Baughman, Verna L. ; Hoffman, William E. ; Albrecht, Ronald F. ; Cwik, Michael ; Paulson, Olaf B. ; Lassen, Niels A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-53d219660649bf194a8614d59a6973efd82316203ae7dfef55752ae1c55a2a6e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Amino Acid Oxidoreductases - antagonists &amp; inhibitors</topic><topic>Animals</topic><topic>Anticonvulsants - metabolism</topic><topic>Arginine - analogs &amp; derivatives</topic><topic>Arginine - pharmacology</topic><topic>Bicuculline</topic><topic>Biological and medical sciences</topic><topic>Cerebral blood flow</topic><topic>Cerebrovascular Circulation - drug effects</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Nitric oxide (NO)</topic><topic>Nitric Oxide - physiology</topic><topic>Nitric Oxide Synthase</topic><topic>Nitroarginine</topic><topic>NMDA receptor</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Seizure</topic><topic>Seizures - chemically induced</topic><topic>Seizures - physiopathology</topic><topic>Stereoisomerism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Qiong</creatorcontrib><creatorcontrib>Theard, Mary A.</creatorcontrib><creatorcontrib>Pelligrino, Dale A.</creatorcontrib><creatorcontrib>Baughman, Verna L.</creatorcontrib><creatorcontrib>Hoffman, William E.</creatorcontrib><creatorcontrib>Albrecht, Ronald F.</creatorcontrib><creatorcontrib>Cwik, Michael</creatorcontrib><creatorcontrib>Paulson, Olaf B.</creatorcontrib><creatorcontrib>Lassen, Niels A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Qiong</au><au>Theard, Mary A.</au><au>Pelligrino, Dale A.</au><au>Baughman, Verna L.</au><au>Hoffman, William E.</au><au>Albrecht, Ronald F.</au><au>Cwik, Michael</au><au>Paulson, Olaf B.</au><au>Lassen, Niels A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>1994-09-26</date><risdate>1994</risdate><volume>658</volume><issue>1</issue><spage>192</spage><epage>198</epage><pages>192-198</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Neurons synthesize NO, which may act as a retrograde messenger, involved in either potentiating or depressing neuronal excitability. NO may also play a role in the cerebral vasodilatory response to increased neuronal activity (i.e., seizures). In this study, two questions were asked: (1) is NO an endogenous anticonvulsant or proconvulsant substance? and (2) is the cerebral blood flow (CBF) increase accompanying bicuculline (BC)-induced seizures mediated by NO? The experiments were performed in 300–400-g Wistar rats anesthetized with 0.6% halothane and 70% N 2O/30% O 2. CBF was measured using the intracarotid 133Xe clearance method or laser-Doppler flowmetry. EEG activity was recorded. Chronic treatment (4 days) with nitro- L-arginine ( L-NA), a potent NO synthase (NOS) inhibitor (400 mg/kg total), suppressed brain NOS by &gt; 97% and prolonged seizure duration from 6±1 (saline-treated controls) to 12 ± 2 min. In the L-NA-treated group, the CBF increase was sustained as long as seizure activity remained, indicating that CBF was still tightly coupled to seizure activity. Interestingly, the supposed inactive enantiomer of L-NA, D-NA, also showed an inhibition of brain NOS activity, ranging from 87 to 100%. The duration of seizures in this group (average 8 ± 2 min) corresponded directly to the magnitude of reduction in NOS activity ( r = 0.83, P &lt; 0.05). Specifically, the D-NA results indicated that NOS inhibition had to exceed 95% before any effect on seizure duration could be seen. Additional results demonstrated that only a total dose of 400 mg/kg of L-NA, given chronically was capable of prolonging the BC-induced CBF increase. With acute doses of 5 and 30 mg/kg L-NA, the time course of CBF changes after BC administration was not different from the control. These findings suggest that endogenous NO acts as an anticonvulsant perhaps via a negative feedback mechanism at the NMDA receptor. NO, however, does not appear to couple neuronal activation to increased CBF in this model.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>7530579</pmid><doi>10.1016/S0006-8993(09)90026-9</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-8993
ispartof Brain research, 1994-09, Vol.658 (1), p.192-198
issn 0006-8993
1872-6240
language eng
recordid cdi_proquest_miscellaneous_16572800
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Amino Acid Oxidoreductases - antagonists & inhibitors
Animals
Anticonvulsants - metabolism
Arginine - analogs & derivatives
Arginine - pharmacology
Bicuculline
Biological and medical sciences
Cerebral blood flow
Cerebrovascular Circulation - drug effects
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Male
Medical sciences
Nervous system (semeiology, syndromes)
Neurology
Nitric oxide (NO)
Nitric Oxide - physiology
Nitric Oxide Synthase
Nitroarginine
NMDA receptor
Rats
Rats, Wistar
Seizure
Seizures - chemically induced
Seizures - physiopathology
Stereoisomerism
title Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T16%3A35%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nitric%20oxide%20(NO)%20is%20an%20endogenous%20anticonvulsant%20but%20not%20a%20mediator%20of%20the%20increase%20in%20cerebral%20blood%20flow%20accompanying%20bicuculline-induced%20seizures%20in%20rats&rft.jtitle=Brain%20research&rft.au=Wang,%20Qiong&rft.date=1994-09-26&rft.volume=658&rft.issue=1&rft.spage=192&rft.epage=198&rft.pages=192-198&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/S0006-8993(09)90026-9&rft_dat=%3Cproquest_cross%3E16572800%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16572800&rft_id=info:pmid/7530579&rft_els_id=S0006899309900269&rfr_iscdi=true